Dr. Malik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8701 Watertown Plank Rd
Hub for Collaborative Medicine, 8th Floor
Milwaukee, WI 53226Phone+1 414-955-0437Fax+1 414-955-0093
Summary
- Dr. Anuj Malik is currently pursuing a Critical Care Fellowship at the Medical College of Wisconsin in Milwaukee. He was previously an Infectious Disease specialist based in Tulsa, OK with a monthly rotating assignment at a residency program in Fresno CA as ID faculty for the Internal Medicine Residency program at St. Agnes Medical Center. He completed his Infectious Disease fellowship at the University of New Mexico School of Medicine from 2012 to 2014. His earlier training includes an Internal Medicine internship at Jewish Hospital of Cincinnati, followed by a residency at Abington Memorial Hospital. He also completed a year of immune compromised host Infectious diseases at Baylor College of Medicine and MD Anderson Medical Center. Dr. Malik earned his MD from Jawaharlal Nehru Medical College in 2000. He has contributed to the medical literature, with publications on topics such as the association between pulmonary artery pressures and atrial fibrillation post-lung transplantation. He has also published on Fostamatinib and was the Principal Investigator for numerous clinical trials at the Ascension St. John Medical Center in Tulsa, OK. He was honored as a Gold Medalist at ACPM Medical College in 1995 and by the Medalsformettle foundation for his work in the COVID pandemic in his community in Tulsa. He was very active during COVID in his community and in addition to being PI for numerous studies, was featured in the local and national media multiple times. For fun, he also was an obesity medicine doctor on TLC's "Family by the ton" show's first season. In his spare time, he likes to bike, play tennis and tinker with his guitar at home.
Education & Training
- University of New Mexico School of MedicineFellowship, Infectious Disease, 2012 - 2014
- Baylor College of MedicineFellowship, Infectious Disease, 2010 - 2011
- Abington Memorial HospitalResidency, Internal Medicine, 2006 - 2008
- Jewish Hospital of CincinnatiInternship, Internal Medicine, 2005 - 2006
- Jawaharlal Nehru Medical CollegeClass of 2000, MD
Certifications & Licensure
- GA State Medical License 2015 - 2027
- CA State Medical License 2008 - 2026
- OK State Medical License 2019 - 2026
- TX State Medical License 2010 - 2026
- WI State Medical License 2024 - 2025
- NM State Medical License 2012 - 2015
- PA State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Obesity Medicine Obesity Medicine
- Join now to see all
Awards, Honors, & Recognition
- Gold Medalist ACPM Medical College, 1995
Clinical Trials
- The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 Start of enrollment: 2020 Jun 09
- The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection Start of enrollment: 2020 Jun 16
- ACTIV-2: A Study for Outpatients With COVID-19 Start of enrollment: 2020 Aug 19
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsElevated pulmonary artery systolic pressures are associated with a lower risk of atrial fibrillation following lung transplantationAnuj Malik, Jonathan C. Hsu, Charles W. Hoopes, Gina Itinarelli, Gregory M. Marcus
Journal of Electrocardiology. 2013-01-01 - The pitfalls of a purely clinical definition of nephrogenic systemic fibrosis: Comment on the article by Todd et alCamille E. Introcaso, Steven M. Brunelli, Joel M. Gelfand, Anuj S. Malik, Miho Murashima
Arthritis and Rheumatism. 2008-05-01
Journal Articles
- Phase 3 Trial of the SYK inhibitor Fostamatinib in patients hospitalized with COVID 19: Protocol and Study Implementation UpdatesLucy Yan, Ziad Mallat, Suzanna Lobo, Anuj Malik, OFID, 12/2/2022
Press Mentions
- Can Rigel’s Bleeding Disorder Drug Fostamatinib Cross over into Covid-19?November 1st, 2021
- Local Health Leaders Embrace CDC Mask Guidance Amid COVID Surge; Bynum Says No Mandate ComingAugust 7th, 2021
- No Mask Order, but Tulsa Mayor Urges End to Vaccine-Hesitancy with Hospital Leaders' GuidanceAugust 6th, 2021
- Join now to see all
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: